Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 840 of 6351
-
Can a glowing light reveal hidden mouth lesions?
Diagnosis CompletedThe aim of the study will be to evaluate the efficacy of a tissue autofluorescence detection system as an aid to clinical screening in identifying lesions of the oral mucosa. The screening process will be performed by 3 clinicians with a different level of experience. Sensitivity…
Sponsor: Federico II University • Aim: Diagnosis
Last updated Sep 04, 2026 00:00 UTC
-
New shot could ease swallowing for eosinophilic esophagitis patients
Disease control CompletedThe purpose of this study is to assess the efficacy and safety of barzolvolimab in adult Eosinophilic Esophagitis patients.
Phase 2 • Sponsor: Celldex Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Smart pump trial aims to ease diabetes management for kids
Disease control Recruiting nowThe goal of this observational study is to describe data on Israeli children and youth using the 780G system including data regarding glycemic control parameters, various questionnaires, sleep data, bioimpedance measures, and dietary parameters. The main questions it aims to answ…
Sponsor: Sheba Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Virtual reality takes on alcohol addiction: a new weapon against relapse?
Disease control CompletedThis study aims to compare the efficacy of virtual reality exposure therapy (VRET) with treatment-as-usual (TAU) for alleviating psychological dependence on alcohol and preventing relapse. It also assesses the changes of EEG in patients with alcohol use disorder after completion …
Sponsor: Universiti Sains Malaysia • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a common diabetes drug reshape PCOS metabolism?
Disease control CompletedThis prospective longitudinal interventional study aims to evaluate the effects of routine metformin therapy on metabolic, iron-related, erythropoietin, lipid, and hematological parameters in adult women with polycystic ovary syndrome (PCOS). Participants diagnosed with PCOS acco…
Phase 4 • Sponsor: Jerash Private University • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Blood test may spot hidden GIST recurrence before scans do
Diagnosis PausedThe goal of this single-center, prospective, observational cohort study is to learn whether tumor-informed minimal residual disease (MRD) testing in blood can predict recurrence in 66 patients with high-risk gastrointestinal stromal tumor (GIST) who are not currently receiving po…
Sponsor: Peking University People's Hospital • Aim: Diagnosis
Last updated Aug 27, 2026 00:00 UTC
-
Mozart's sonata may tame seizures in children
Symptom relief OngoingMozart's Sonata for two pianos in D major (K448) has been found to reduce the presence of abnormalities in the electroencephalograms of patients with epilepsy. We will examine the long term effects of listening to the K448 sonata on seizure frequency and cognitive functioning in …
Sponsor: University of Aberdeen • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
New drug combo aims to shrink pancreatic tumors before surgery
Disease control CompletedThis study is designed to explore the efficacy and safety of surufatinib combined with gemcitabine and nab-paclitaxel as peri-operative treatment in locally advanced or borderline resectable pancreatic cancer.
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Could infusions of cell 'Packages' repair failing hearts?
Disease control OngoingThe goal of this clinical trial is to assess the safety and efficacy of three intravenous injections of the extracellulat vesicle-enriched secretome of cardiovascular progenitor cells in severely symptomatic patients with drug-refractory left ventricular (LV) dysfunction secondar…
Phase 1 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New eczema drug shows promise in Long-Term safety trial for thousands
Disease control Stopped earlyThe primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD.
Phase 3 • Sponsor: Amgen • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Could a gut pill ease long COVID? new trial tests larazotide
Disease control CompletedThe primary objective of this study is to evaluate the safety and efficacy of Larazotide (AT1001) versus placebo in children and adults 7 to ≤50 years of age who present with symptoms of Long COVID in the presence of SARS-CoV-2 antigenemia. AT1001 (n=100) or placebo (n=50) will b…
Phase 2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Hope for rare muscle disease: new drug enters final testing phase
Disease control OngoingThis study will evaluate the safety and efficacy of long-term administration of BBP-418 in patients with LGMD2I/R9. The study will include patients ages 12 to 60, consistent with the existing preclinical toxicology profile. This will encompass the significant majority of existing…
Phase 3 • Sponsor: ML Bio Solutions, Inc. • Aim: Disease control
Last updated Sep 10, 2026 02:00 UTC
-
New drug cocktail aims to wipe out Hard-to-Treat blood cancers
Disease control Recruiting nowThis phase II trial is to evaluate the effects of acalabrutinib in combination with venetoclax in treating patients with chronic lymphocytic leukemia or small lymphocytic lymphoma that does not respond to treatment (refractory) or that has come back (recurrent). Acalabrutinib may…
Phase 2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Weight loss pill shows promise in chinese adults: phase 3 trial complete
Disease control CompletedThis study is being conducted to see if semaglutide tablets can be used as a treatment to help people who are above a healthy weight range to lose weight. Semaglutide tablets are a new medicine being tested to treat people living with excess body weight. Participants will either …
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New shot could stop painful swelling attacks in kids
Disease control CompletedThe purpose of this study is to investigate the safety, PK / PD, and efficacy of SC CSL312 for prophylactic treatment of pediatric subjects with HAE.
Phase 3 • Sponsor: CSL Behring • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
One-Stop health check: can integrated care tame HIV and heart disease together?
Disease control CompletedThe purpose of this study is to evaluate the effects of a multi-level intervention known as "TASKPEN," adapted from the World Health Organization (WHO) Package of Essential Noncommunicable Disease Interventions (WHO-PEN) for the Zambian public health system, on clinical and imple…
Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
One infusion could beat daily pills for Post-Birth anemia
Disease control CompletedPRIORITY is designed as a 2-arm, randomized-controlled trial focused on postpartum women. The trial will recruit women who are diagnosed with moderate anemia based on a blood sample taken 6-48 hours after childbirth. A total of 4,800 eligible women, or 600 women per research site…
Phase 3 • Sponsor: NICHD Global Network for Women's and Children's Health • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New gel could speed healing of diabetic foot sores
Disease control Recruiting nowThis Phase 3 study is a randomized, double-blind, vehicle-controlled, multiple-center, parallel study to evaluate efficacy and safety of ENERGI-F703 GEL compared with vehicle control in subjects with Wagner Grade 1 to Grade 2 diabetic foot ulcers. Baseline target ulcer size (\<16…
Phase 3 • Sponsor: Energenesis Biomedical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New pill combo aims to cure hepatitis c in just 8 weeks
Disease control CompletedThis is an open-label trial to evaluate safety and efficacy of treatment with BEM + RZR in subjects with chronic HCV infection.
Phase 2 • Sponsor: Atea Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New hope for schizophrenia: KarXT shows promise in major trial
Disease control CompletedA Phase 3, Multicenter, Two-part Study with a 5-week Double-blind Part (Randomized, Parallel-group, Placebo-controlled) followed by a 12-week Open-label Extension Part, to Evaluate the Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Chinese Adult Subjects with DSM-…
Phase 3 • Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC